1 documents found
Information × Registration Number 0212U008739, 0107U003845 , R & D reports Title Functional diseases of the esophagus, stomach, duodenum: comparative data of intraluminal-pH-monitoring and study efficiency of antisecretory drugs, psychotropic drugs, prokinetics, cytoprotectors and eradication of Helicobacter pylori popup.stage_title Head Chernobrovyi Viacheslav Mykolaiovich, Доктор медичних наук Registration Date 29-12-2012 Organization Dovganeuk Inna popup.description2 By means of epidemiological survey of the 1307 adults living in GP-district, it was determined that the most common functional gastrointestinal disorder is a functional dyspepsia (FD) affecting 24.3% of the adult population (or 18.75% of the total). FD is divided on several types: epigastric pain syndrome (EBS) - 28.13%, postprandial distress syndrome (PDS) - 56.25%, non-specific - 15.63%. Esophago-gastro-pH-metry (monitoring), which were performed on 178 patients with FD and 247 patients in the control group (GERD, peptic ulcers), significantly improved the diagnostic capabilities. In particular, one-quarter of patients FD demonstrates abnormal gastroesophageal reflux, which requires a long-term therapy. 5% of patients have atrophic gastropathy with hypo-anacidity, making impossible traditional prescribing of antisecretory drugs. Basic therapy with proton pump inhibitors (PPI) does not reach the required level of acidoinhibition in quarter of patients and requires conducting of pH-monitoring to adjust the dose of PPI or addition 150 mg ranitidine at night. The sensitivity of patients with FD to PPI is lower than in peptic ulcers , significantly increases in case of HP- infection and doesn't depend from the type of PPI. In the subjective resistance to PPIs it is worth to prescribe 500 mg "Phenibut" BID, which reduces anxiety, normalizes autonomic dysfunction and eliminates depression to the 30-th day of treatment . This therapy is indicated for FD-patients overlaped with IBS (up to 34.7% of FD). In case of FD-PDS PPI's efficacy obvious increases by adjunctive taking of 10mg domperidone TID. Same situation is observed in cases of FD with erosive gastroduodenopathy when 100 mg rebamipide TID prescribed. Product Description popup.authors Заїка С.В. Колісник С.П. Мелащенко С.Г. Миршук Н.М. Півторак Н.А Палій І.Г. Чернова І.В. popup.nrat_date 2020-04-02 Close
R & D report
Head: Chernobrovyi Viacheslav Mykolaiovich. Functional diseases of the esophagus, stomach, duodenum: comparative data of intraluminal-pH-monitoring and study efficiency of antisecretory drugs, psychotropic drugs, prokinetics, cytoprotectors and eradication of Helicobacter pylori. (popup.stage: ). Dovganeuk Inna. № 0212U008739
1 documents found

Updated: 2026-03-23